<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20211127053190N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-12-01</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of cardiovascular effects of ropevacaine and lidocaine with epinephrine in implant surgery</public_title>
      <acronym></acronym>
      <scientific_title>Comparative evaluation of cardiovascular effects of 0.5% Ropivacaine front 2% Lidocaine with 1:80000 epinephrine in implant surgery, A double-blind crossover clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2021-12-13</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>18</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/60268</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: After the patient's eligibility is determined, the procedure will be explained to the patient and moral satisfaction will be obtained. A simple randomization method is used. The surgical site as well as the type of local anesthesia in the first session are both determined by dropping the coin by the assistant. Both sides (left and right)  in a jaw will recieve 1 implant with the same surgical procedure without bone augmentation. Two weeks later, surgery will be performed on the other side with the other anesthetic drug, Blinding description: After determining the type of anesthesia for the first session by dropping the coin, the assistant draws up the drug into the insulin syringes, and delivers it to the surgeon. The assistant will be the only aware person of the type of drug and has no role in further procedures. Both anesthetic drugs are colorlessness and clear, so the insulin syringes will not be covered. After completing the injection and starting the surgery, the parameters are recorded by the surgeon. Both the patient and the surgeon are unaware of the type of local anesthesia.</study_design>
      <phase>2</phase>
      <hc_freetext>Hemodynamic effects.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: 3.6 millilitre of the anaesthetic solution is drawn with insulin syringes from 10 millilitre vial of 0.5% ropivacaine made by Molteni Pharmaceutical Company.  The injection technique in lower jaw is buccal and lingual infiltration (1 millilitre and 1 millilitre), and in upper jaw is buccal infiltration and greater palatine block (1.5 millilitre and 0.5 millilitre). Then performing the surgical steps of placing a dental implant begins. Intervention 2: Control group: 3.6 millilitre of the anaesthetic solution is drawn with insulin syringes from 1.8 millilitre carpules of 2% lidocaine with epinephrine 1/80000 made by Darou Pakhsh Pharmaceutical Company. The injection technique in lower jaw is buccal and lingual infiltration (1 millilitre and 1 millilitre), and in upper jaw is buccal infiltration and greater palatine block (1.5 millilitre and 0.5 millilitre). Then performing the surgical steps of placing a dental implant begins.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Negar Daneshvar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid beheshti dental school, Daneshjoo Blvd, Evin, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 2240 3010</telephone>
        <email>dr.negardaneshvar@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Negar Daneshvar</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid beheshti dental school, Daneshjoo Blvd, Evin, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1983969411</zip>
        <telephone>+98 21 2240 3010</telephone>
        <email>dr.negardaneshvar@sbmu.ac.ir</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients  who need to place 1 implant bilaterally in the posterior areas (premolar or molar) in one jaw
Systemically healthy individuals (ASA I)</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>70 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients with a history of allergy to local anesthetic agents, amides and sulfides
Patients with acute or chronic infection near the surgical site
Smokers
Alcohol consumption
Consumers of antipsychotic drugs, antidepressants and oral contraceptives
People who have taken painkillers in the 48 hours before surgery
People with a history of chronic facial pain
Pregnant and lactating women
Patients who need immediate implant placement (class1)
Patients who need open / closed sinus lift surgery at the surgical site
Patients who need bone augmentation (GBR) at the surgical site
Patients who refuse to take part in the research</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: 3.6 millilitre of the anaesthetic solution is drawn with insulin syringes from 10 millilitre vial of 0.5% ropivacaine made by Molteni Pharmaceutical Company.  The injection technique in lower jaw is buccal and lingual infiltration (1 millilitre and 1 millilitre), and in upper jaw is buccal infiltration and greater palatine block (1.5 millilitre and 0.5 millilitre). Then performing the surgical steps of placing a dental implant begins.</i_keyword>
      <i_keyword>Control group: 3.6 millilitre of the anaesthetic solution is drawn with insulin syringes from 1.8 millilitre carpules of 2% lidocaine with epinephrine 1/80000 made by Darou Pakhsh Pharmaceutical Company. The injection technique in lower jaw is buccal and lingual infiltration (1 millilitre and 1 millilitre), and in upper jaw is buccal infiltration and greater palatine block (1.5 millilitre and 0.5 millilitre). Then performing the surgical steps of placing a dental implant begins.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Heart rate. Timepoint: Before the injection, immediately after the injection, 10 minutes after the injection, 20 minutes after the injection, 30 minutes after the injection, 1 hour after the injection. Method of measurement: Pulse Oximeter.</prim_outcome>
      <prim_outcome>Systolic blood pressure. Timepoint: Before the injection, immediately after the injection, 10 minutes after the injection, 20 minutes after the injection, 30 minutes after the injection, 1 hour after the injection. Method of measurement: Wrist Blood Pressure Monitor.</prim_outcome>
      <prim_outcome>Diastolic blood pressure. Timepoint: Before the injection, immediately after the injection, 10 minutes after the injection, 20 minutes after the injection, 30 minutes after the injection, 1 hour after the injection. Method of measurement: Wrist Blood Pressure Monitor.</prim_outcome>
      <prim_outcome>Saturation of Peripheral Oxygen (SPo2). Timepoint: Before the injection, immediately after the injection, 10 minutes after the injection, 20 minutes after the injection, 30 minutes after the injection, 1 hour after the injection. Method of measurement: Pulse Oximeter.</prim_outcome>
      <prim_outcome>Onset of anesthesia. Timepoint: From the time when the needle is pulled out of the tissue. Method of measurement: Stopwatch.</prim_outcome>
      <prim_outcome>Duration of anesthesia. Timepoint: From the time when the needle is pulled out of the tissue until the anesthetic effect wears off. Method of measurement: Stopwatch.</prim_outcome>
      <prim_outcome>The amount of pain felt during the injection. Timepoint: During the injection. Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>The amount of pain felt during the surgery. Timepoint: During the surgery. Method of measurement: Visual Analogue Scale.</prim_outcome>
      <prim_outcome>Duration of analgesia after the surgery. Timepoint: From the time when the needle is pulled out of the tissue until the time of  the onset of pain after the surgery. Method of measurement: Stopwatch.</prim_outcome>
      <prim_outcome>Numbers of painkillers taken after the surgery. Timepoint: After the end of the surgery to 1 week. Method of measurement: questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-08-25</approval_date>
        <contact_name>Ethics committee of Shahid Beheshti University of Medical Sciences</contact_name>
        <contact_address>Shahid Beheshti School of Dentistry, Daneshjou Blvd, Evin, Tehran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
